Brief: Viveve Medical Announces Topline Results From U.S. Trial For Improvement Of Sexual Function In Women
09/04/2020 14:02
April 9 (Reuters) - Viveve Medical Inc VIVE.O :
* VIVEVE MEDICAL - ANNOUNCES TOPLINE RESULTS FROM PIVOTAL
U.S.
VIVEVE II TRIAL FOR IMPROVEMENT OF SEXUAL FUNCTION IN WOMEN
* VIVEVE MEDICAL - VIVEVE II STUDY DID NOT MEET ITS PRIMARY
ENDPOINT
* VIVEVE MEDICAL - IN LIGHT OF THE VIVEVE II TRIAL OUTCOME &
CURRENT COVID-19 PANDEMIC, COMPANY CURRENTLY EVALUATING
STRATEGIC ALTERNATIVES
Source text for Eikon: [ID:https://bit.ly/2Vd31Qk]
Further company coverage: VIVE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viveve Medical
See all newsU.S. STOCKS ON THE MOVE-Chord Energy, Kroger, PetMed Express
U.S. STOCKS ON THE MOVE-DoorDash, Walt Disney, Tesla
U.S. STOCKS ON THE MOVE-Papa John's, Whirlpool, Coca-Cola
Viveve Medical plunges as urinary disease drug fails to meet main goal
Brief: Viveve Medical Inc - Company Will Seek Strategic Alternatives And Will Be Delisted From Nasdaq